Table 1 Demographic characteristics and covariates in HCV patients (carriers) treated with and without aspirin
Variables | Aspirin | p value* | |||
|---|---|---|---|---|---|
No (N = 1911) | Yes (N = 1911) | ||||
n | % | n | % | ||
Gender | 0.33 | ||||
 Female | 1027 | 53.7 | 997 | 52.2 |  |
 Male | 884 | 46.3 | 914 | 47.8 |  |
Age, years | 0.01 | ||||
  < 40 | 98 | 5.13 | 96 | 5.02 |  |
 40–59 | 606 | 31.7 | 580 | 30.4 |  |
 60–79 | 936 | 49.0 | 1025 | 53.6 |  |
  ≥ 80 | 271 | 14.2 | 210 | 11.0 |  |
 Mean (SD) | 64.6 | 14.4 | 64.3 | 13.5 | 0.58†|
Baseline comorbidity | |||||
 Hypertension | 1462 | 76.5 | 1410 | 73.8 | 0.05 |
 Diabetes mellitus | 905 | 47.4 | 848 | 44.4 | 0.06 |
 Moderate or severe liver disease | 34 | 1.78 | 23 | 1.2 | 0.14 |
 Myocardial infarction | 123 | 6.44 | 133 | 6.96 | 0.52 |
 Congestive heart failure | 431 | 22.6 | 429 | 22.5 | 0.94 |
 Ischemic stroke | 1245 | 65.2 | 1212 | 63.4 | 0.27 |
Drugs | |||||
 Anti-hypertensive agents | 1003 | 52.5 | 1506 | 78.8 | < 0.001 |
 Hypoglycemic agents | 114 | 5.97 | 141 | 7.38 | 0.08 |
 Coumadin and heparin | 55 | 2.88 | 175 | 9.16 | < 0.001 |
 Other antithrombotic agents | 153 | 8.01 | 491 | 25.7 | < 0.001 |
 NSAIDs | 931 | 48.7 | 1140 | 59.7 | < 0.001 |